These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19506368)

  • 21. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypertension--main risk factor of stroke. Results of a three years register in Krasnodar].
    Kharakoz OS; Kanorskiĭ SG; Shchelchkova IS; Kizhvatova NV; Varakin IuIa; Vereshchagin NV
    Kardiologiia; 2002; 42(10):31-5. PubMed ID: 12494054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twenty-Year Time Trends in Long-Term Case-Fatality and Recurrence Rates After Ischemic Stroke Stratified by Etiology.
    Rücker V; Heuschmann PU; O'Flaherty M; Weingärtner M; Hess M; Sedlak C; Schwab S; Kolominsky-Rabas PL
    Stroke; 2020 Sep; 51(9):2778-2785. PubMed ID: 32811383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study.
    Mancusi C; Gerdts E; de Simone G; Midtbø H; Lønnebakken MT; Boman K; Wachtell K; Dahlöf B; Devereux RB
    Blood Press; 2017 Jun; 26(3):150-155. PubMed ID: 27710139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of hypertension 5 years after stroke in the North East Melbourne Stroke Incidence Study.
    Paul SL; Thrift AG
    Hypertension; 2006 Aug; 48(2):260-5. PubMed ID: 16785330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada.
    Campbell NR; Brant R; Johansen H; Walker RL; Wielgosz A; Onysko J; Gao RN; Sambell C; Phillips S; McAlister FA;
    Hypertension; 2009 Feb; 53(2):128-34. PubMed ID: 19114646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Older age should not be a barrier to the treatment of hypertension.
    Aronow WS
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):514-5. PubMed ID: 18607394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
    Suadicani P; Hein HO; Gyntelberg F
    Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Adherence to Antihypertensive Medication on the Long-Term Outcome After Hemorrhagic Stroke in Korea.
    Kim J; Bushnell CD; Lee HS; Han SW
    Hypertension; 2018 Aug; 72(2):391-398. PubMed ID: 29915019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group.
    Wassertheil-Smoller S; Fann C; Allman RM; Black HR; Camel GH; Davis B; Masaki K; Pressel S; Prineas RJ; Stamler J; Vogt TM
    Arch Intern Med; 2000 Feb; 160(4):494-500. PubMed ID: 10695689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of Recurrent Ischemic Stroke in Obese Patients With Type 2 Diabetes Mellitus: A Population-based Study.
    Albitar O; Harun SN; Abidin NE; Tangiisuran B; Zainal H; Looi I; Ibrahim KA; Sidek NN; Loo KW; Lee KY; Aziz ZA; Ghadzi SMS
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105173. PubMed ID: 32912507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The disparity in long-term survival after a first stroke in patients with and without diabetes persists: the Northern Sweden MONICA study.
    Eriksson M; Carlberg B; Eliasson M
    Cerebrovasc Dis; 2012; 34(2):153-60. PubMed ID: 22907276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research.
    Lewis JD; Schinnar R; Bilker WB; Wang X; Strom BL
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):393-401. PubMed ID: 17066486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial.
    Robinson TG; Potter JF; Ford GA; Bulpitt CJ; Chernova J; Jagger C; James MA; Knight J; Markus HS; Mistri AK; Poulter NR;
    Lancet Neurol; 2010 Aug; 9(8):767-75. PubMed ID: 20621562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of ischemic stroke in normotensive and hypertensive diabetic patients with or without antihypertensive treatment: an 8-year followup study.
    Yoshinari M; Kaku R; Iwase M; Iino K; Yamamoto M; Satou Y; Minami M; Kodama T; Fujishima M
    J Diabetes Complications; 1997; 11(1):9-14. PubMed ID: 9025007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive treatment in the very elderly shows significant mortality benefit.
    Cardiovasc J Afr; 2008; 19(3):169-71. PubMed ID: 18568185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.